Will Zepbound price drop by 20% or more by June 30, 2025? | Binary | | | 12 days ago | |
Will FDA issue warning or ban on compounded GLP-1 drugs by end of 2025? | Binary | | | 12 days ago | |
Will Hims & Hers Health stock price fall below $5 by end of 2024? | Binary | | | 4 months ago | |
Will Eli Lilly's Zepbound sales exceed $500 million by the end of Q4 2024? | Binary | | | 4 months ago | |
Will Ro-Lilly partnership boost Zepbound prescriptions by 50% by end of 2025? | Binary | | | 12 days ago | |
Hims & Hers Health, Inc. stock recovers to pre-announcement level by Q1 2025? | Binary | | | 12 days ago | |
What will Eli Lilly's Q4 2024 revenue be? | Categorical | | | 4 months ago | |
Will Eli Lilly's market share in weight-loss drugs exceed 30% by end of 2024? | Binary | | | 4 months ago | |
Will Eli Lilly's stock price exceed $600 by end of 2024? | Binary | | | 4 months ago | |
Will Hims & Hers Health stock recover to its pre-announcement level by the end of 2024? | Binary | | | 4 months ago | |
What will be the price of Eli Lilly's stock by the end of 2024? | Categorical | | | 4 months ago | |
Will PfizerForAll platform expand to 5 new countries by June 30, 2025? | Binary | | | 4 months ago | |
Will PfizerForAll platform partner with another major pharmacy chain by March 31, 2025? | Binary | | | 4 months ago | |
What will be the market share change between Zepbound and Wegovy by end of 2025? | Categorical | | | 12 days ago | |
How many new partnerships will Eli Lilly form for Zepbound by end of 2025? | Categorical | | | 12 days ago | |
Eli Lilly's Zepbound sales increase by more than 20% in Q1 2025? | Binary | | | 12 days ago | |
Impact of Ro's partnership with Eli Lilly on customer base by mid-2025? | Categorical | | | 12 days ago | |
Ro faces legal challenges over Zepbound distribution by end of 2024? | Binary | | | 12 days ago | |
Eli Lilly's Zepbound market share in weight-loss drugs by end of 2025? | Categorical | | | 12 days ago | |
Leader in GLP-1 weight-loss drug market by end of 2025? | Categorical | | | 12 days ago | |
How will Zepbound price reduction impact patient access by end of 2024? | Categorical | | | 4 months ago | |
What will be the impact on Eli Lilly's market share in weight-loss drugs by end of 2024? | Categorical | | | 4 months ago | |
Which company will be the leader in the weight-loss drug market by the end of 2024? | Categorical | | | 4 months ago | |
Will Eli Lilly face any legal challenges regarding Zepbound pricing by mid-2024? | Binary | | | 4 months ago | |
What will be Eli Lilly's Zepbound market share in the weight-loss drug market by the end of Q1 2025? | Categorical | | | 4 months ago | |
Will PfizerForAll platform reach 1 million users by December 31, 2024? | Binary | | | 4 months ago | |
Which will be the most popular service on PfizerForAll platform by December 31, 2024? | Categorical | | | 4 months ago | |
Who will be PfizerForAll platform's first major competitor by June 30, 2025? | Categorical | | | 4 months ago | |
How many conditions will be covered by PfizerForAll platform by December 31, 2024? | Categorical | | | 4 months ago | |
How will public opinion on GLP-1 drug affordability change by end of 2025? | Categorical | | | 12 days ago | |
